Michelle Brennan served as the Interim Chief Executive Officer at Masimo Corporation, a global medical technology company known for its innovative patient monitoring solutions. Brennan stepped into the role during a transitional period for the company, demonstrating her leadership and commitment to Masimo's mission of improving patient outcomes through advanced technology. Prior to her appointment as Interim CEO, Brennan held the position of Chief Financial Officer at Masimo, where she played a pivotal role in the company's financial strategy and growth. Brennan's professional background is marked by a strong track record in finance and executive leadership within the healthcare industry. Before joining Masimo, she served in various financial leadership roles at other prominent healthcare companies, where she honed her expertise in financial management and strategic planning. Her tenure at Masimo was characterized by her ability to navigate complex financial landscapes and drive the company towards sustainable growth. Under her leadership as CFO, Masimo achieved significant milestones, including the expansion of its product portfolio and the strengthening of its market position. As Interim CEO, Brennan focused on maintaining the company's stability and advancing its strategic initiatives. Her leadership was instrumental in ensuring a smooth transition during a critical time for Masimo. Brennan's contributions to the company extended beyond her financial acumen; she was also known for her dedication to fostering a culture of innovation and excellence. Although her time as Interim CEO was temporary, her impact on Masimo Corporation remains a testament to her leadership and vision in the medical technology sector.